These core metrics can express better than HbA1C glycemic variability, acute excursion of glucose change and severity of hypo and hyperglycemia, all clinical situations that could require a more intensive self-monitoring of blood glycemia or insulin self-administration, which might instead be voluntarily omitted due to the level of needle phobia. This evidence concerns the gene INS and Hyperglycemia.